NTLA | 3.50% | 13.11 | -3.57% | 5,722 | |
DNA | 3.33% | 13.960 | 0.00% | 5,307 | |
CRSP | 3.30% | 63.75 | -1.56% | 1,131 | |
SANA | 3.19% | 4.88 | -1.41% | 14,298 | |
NSISb | 2.51% | 440.2 | -0.59% | 802 | |
AGIO | 2.26% | 37.20 | -7.00% | 1,256 | |
LLY | 2.23% | 807.80 | -0.60% | 61 | |
EDIT | 2.21% | 2.96 | -6.03% | 15,619 | |
BEAM | 2.16% | 20.83 | -4.10% | 2,206 | |
TXG | 2.13% | 14.65 | +3.83% | 3,353 |
WisdomTree Trust - WisdomTree BioRevolution Fund is an exchange traded fund launched by WisdomTree, Inc. The fund is co-managed by WisdomTree Asset Management, Inc., Mellon Investments Corporation. It invests in public equity markets of global region. The fund invests in stocks of companies operating across heath care, pharmaceuticals, biotechnology and life sciences, biotechnology, agricultural biotechnology, biotechnology research equipment manufacturers, genetic technologies sectors. It invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track the performance of the WisdomTree BioRevolution Index, by using representative sampling technique. WisdomTree Trust - WisdomTree BioRevolution Fund was formed on June 3, 2021 and is domiciled in the United States.